跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,742 条关于
“DMPK RNA”
全部
6,742
临床试验
3,356
药物
1,271
机构
28
资讯
2,087
去年
Dyne Therapeutics' DYNE-101 Shows Promise for Accelerated Approval Pathway in DM1
去年
Dyne Therapeutics' DYNE-101 Shows Promise in DM1 Trial, FDA Grants Fast Track Designation
10天前
Novartis' Del-desiran Misses Primary Endpoint in Phase 3 HARBOR, Rattling DMPK-Targeting Field
11个月前
Dyne Therapeutics Reports Sustained One-Year Functional Improvements with Zeleciment Basivarsen in Myotonic Dystrophy Type 1
3个月前
Biocon Academy Graduates 156 Students at 10th Convocation, Launches New AI and DMPK Programs
去年
ARTHEx Biotech Secures $87M Series B to Advance Novel RNA Therapy for Myotonic Dystrophy Type 1
10个月前
PepGen Secures U.S. Patent for PGN-EDODM1, Advancing Myotonic Dystrophy Type 1 Treatment
去年
FDA Lifts Clinical Hold on Avidity's Delpacibart Etedesiran (AOC 1001) for Myotonic Dystrophy Type 1
7个月前
Avidity's Del-desiran Shows Promise for Myotonic Dystrophy Type 1 in Phase 1/2 MARINA Trial Published in NEJM
6个月前
ARTHEx Biotech Receives FDA Fast Track Designation for ATX-01 in Myotonic Dystrophy Type 1
第 1 页,共 209 页
上一页
下一页